Ovascience (OVAS) Misses Q4 EPS by 20c

Ovascience (NASDAQ: OVAS) reported Q4 EPS of ($0.79), $0.20 worse than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Ovascience (OVAS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Reading (RDI) Tops Q2 EPS by 4c